Bipolar Disorder research opportunities

Bipolar Disorder clinical trials recruiting in the United States

Explore currently listed bipolar disorder studies with reported U.S. locations and compare public study and eligibility information. Compare age range, phase, sponsor, and public eligibility information before contacting an official study team.

22 recruiting studies 145 reported study locations

Find bipolar disorder studies near you

Enter a U.S. ZIP code to compare studies by distance from reported study sites.

Featured recruiting bipolar disorder studies

Age: 10 Years – 17 YearsPhase: PHASE3Reported sites: 68Sponsor: Intra-Cellular Therapies, Inc.

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).

Age: 18 Years and olderPhase: PHASE2Reported sites: 33Sponsor: AbbVie

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. This study will assess how safe and effective Icalcaprant is in treating adult participants with bipolar I or II disorder. Icalcaprant is an investigational drug being developed for the treatment of depressive episodes in adult participants with bipolar I or II disorder. Participants are placed in 1 of 3 groups, called treatment arms. There is a 1 in 3 chance…

Age: 18 Years and olderPhase: PHASE4Reported sites: 19Sponsor: Neurocrine Biosciences

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

Age: 22 Years and olderPhase: NAReported sites: 4Sponsor: Wayne Goodman MD

This study is only enrolling at Baylor College of Medicine. The other research locations listed serve to support data analysis only. This research study is to investigate the use of technology called Deep Brain Stimulation (DBS) to potentially improve Treatment-Resistant Bipolar Depression (TRBD) symptoms in patients with severe cases. DBS involves the surgical implantation of leads and electrodes into specific areas of the brain, which are thought to influence the disease. A pack implanted in the chest, called…

Age: 18 Years and olderPhase: NAReported sites: 3Sponsor: VA Office of Research and Development

Over 60% of Veterans with serious mental illness have a service-connected disability that impairs their ability to work, go to school, and/or have successful personal lives. Although traditional treatments tend to focus on symptom remission, Veterans prioritize a range of treatment goals, including personal empowerment and gaining personally meaningful skills. Increasing Veteran-clinician collaboration can help effectively align care with each Veteran's goals and support an empowering therapeutic experience. This…

Age: 18 Years and olderPhase: Not ApplicableReported sites: 2Sponsor: University of Chicago

This study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators have developed a Transition Care Team (TCT) that works with patients while they are in the hospital and continues to support them after discharge. The team provides therapy, case management, and coordination with community programs that…

Age: 3 Years – 99 YearsPhase: Not ApplicableReported sites: 1Sponsor: National Institute of Mental Health (NIMH)

The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols in the Experimental Therapeutics and Pathophysiology Lab (ETPB) at the National Institute of Mental Health (NIMH) and for the collection of natural history data. In addition the protocol will allow clinicians to gain more experience in the use of a variety of polysomnographic and high-density EEG recordings. Subjects in this protocol will undergo an evaluation which may…

Age: 22 Years – 70 YearsPhase: NAReported sites: 1Sponsor: Icahn School of Medicine at Mount Sinai

This study addresses a critical unmet need in the treatment of bipolar disorder by investigating whether Subcallosal Cingulate (SCC) Deep Brain Stimulation (DBS) can safely and effectively treat treatment-resistant bipolar depression without inducing manic switches. The researchers propose to accomplish this by incorporating monitoring of the SCC local field potentials (LFP) for depression tracking and amygdala LFP monitoring for mania prediction while treating Bipolar I patients with SCC DBS Stimulation. This…

Age: 18 Years and olderPhase: NAReported sites: 1Sponsor: Temple University

The goal of this research is to investigate whether a peer-delivered illness self-management program called Taking Action can help college students with serious mental illnesses. Participants will be randomly assigned to either the experimental condition (Taking Action) or the control condition (information only). Participants in the experimental condition will attend five 2.5-hour Taking Action sessions. Participants will complete three interviews (baseline, post-intervention, and follow-up) to assess how well…

Age: 18 Years and olderPhase: Not ApplicableReported sites: 1Sponsor: Mayo Clinic

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.

Age: 18 Years – 55 YearsPhase: PHASE1, PHASE2Reported sites: 1Sponsor: Laureate Institute for Brain Research, Inc.

This is a 2x2, within-subjects, cross-over trial to test the anti-depressant effects of acute exercise in 20 participants with bipolar depression. Participants will complete four experimental sessions, two with an exercise challenge and two with a resting control condition in a counterbalanced order. Participants will receive either 800mg of ibuprofen or placebo before exercise or rest in order to test whether blocking the inflammatory response to exercise interferes with the neural and psychological effects of…

Age: 18 Years – 65 YearsPhase: PHASE2Reported sites: 1Sponsor: Mclean Hospital

Preliminary data have suggested that cannabidiol (CBD) may have a number of clinical benefits, including anti-anxiety and antidepressant properties. This study is a pilot open-label clinical trial assessing a custom-formulated high-CBD product over the course of 4 weeks in patients with bipolar disorder who experience anxiety.

Age: 18 Years – 25 YearsPhase: NAReported sites: 1Sponsor: Weill Medical College of Cornell University

This study aims to compare the effectiveness of a standard mobile cognitive behavioral therapy program to a personalized mobile cognitive behavioral therapy program that introduces new skills over a shorter period of time. Participants will use the Maya app for two days per week, at least 20 minutes per day, for six weeks. Assessments will include a weekly check in with a member of the research team, questionnaires, and optional electroencephalographic (EEG) recordings at the beginning and end of the 6-week…

Age: 18 Years – 65 YearsPhase: NAReported sites: 1Sponsor: Massachusetts General Hospital

This is a randomized controlled trial investigating the effects of an 8-TRE intervention compared to a wait list (control) on metabolic health and body composition in people diagnosed with BD and who are currently obese and at least mildly depressed. Following a 1-week baseline assessment, participants will be randomized to either a TRE or the wait list (1-to-1 ratio) for 8 weeks. At baseline, Week 8 (post treatment), and Week 20 (follow-up), investigators will assess daily eating patterns for one week, followed…

Age: 18 Years and olderPhase: NAReported sites: 1Sponsor: VA Office of Research and Development

Many individuals with serious mental illness have difficulty accurately interpreting interpersonal cues and effectively engaging in social exchanges. Difficulties related to the interpersonal aspects of work can lead to isolation, poor productivity, and job loss. The goals of this study are to: 1) adapt an evidence-based social cognitive skills intervention for work settings and use with Veterans, 2) examine the acceptability of the work focused skills training intervention, 3) assess the feasibility of combining…

Age: 18 Years and olderPhase: PHASE4Reported sites: 1Sponsor: Weill Medical College of Cornell University

This study is exploring a new approach to treating depression in people with bipolar disorder (BD). Investigators are testing whether a non-invasive form of brain stimulation can help us understand depressed-to-euthymic mood shifts and their related brain circuits in BD. Investigators in this study will use a technique called repetitive transcranial magnetic stimulation, or rTMS. It uses non-invasive magnetic pulses delivered to the scalp to stimulate specific areas of the brain. rTMS is already used to treat…

Age: 22 Years and olderPhase: NAReported sites: 1Sponsor: Andrew Krystal

Neurons are specialized types of cells that are responsible for carrying out the functions of the brain. Neurons communicate with electrical signals. In diseases such as major depression this electrical communication can go awry. One way to change brain function is using electrical stimulation to help alter the communication between groups of neurons in the brain. The purpose of this study is to test a personalized approach to brain stimulation as an intervention for bipolar depression The study researchers will…

Age: 25 Years and olderPhase: PHASE2Reported sites: 1Sponsor: The University of Texas Health Science Center, Houston

The purpose of the study is to assess the safety and acceptability of up to two sequential administrations of 25 mg psilocybin with additional therapeutic support in decreasing suicidality in patients with Bipolar Disorder (BD II) depression.

Age: 8 Years and olderPhase: Not ApplicableReported sites: 1Sponsor: National Institute of Mental Health (NIMH)

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse substances. In this natural history study, researchers would like to learn more about the connection between exercise and mental health in people with and without mood disorders. Objective: To better understand relationships among physical activity, sleep, and mental health. Eligibility: People aged 8 to 60 years with a history of a…

What eligibility can depend on

Each protocol is different. Study teams may consider diagnosis details, disease characteristics, prior treatments, age, general health, and the ability to attend required visits.

Before contacting a study

Review the official listing and consider having your diagnosis and treatment history available. Only the study team can confirm whether a trial may be appropriate.

Questions to ask

Ask about the study purpose, procedures, possible risks and benefits, visit schedule, travel, costs, and whether reimbursement is available.

Important: Varda Clinical is an independent discovery tool. It does not provide medical advice, recommend treatment, or determine eligibility. Verify study details with the official research team and discuss participation with a qualified healthcare professional.